Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms.

Dietrich EA, Langevin SA, Huang CY, Maharaj PD, Delorey MJ, Bowen RA, Kinney RM, Brault AC.

PLoS Negl Trop Dis. 2016 Aug 22;10(8):e0004938. doi: 10.1371/journal.pntd.0004938. eCollection 2016 Aug.

2.

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).

Huang CY, Kinney RM, Livengood JA, Bolling B, Arguello JJ, Luy BE, Silengo SJ, Boroughs KL, Stovall JL, Kalanidhi AP, Brault AC, Osorio JE, Stinchcomb DT.

PLoS Negl Trop Dis. 2013 May 30;7(5):e2243. doi: 10.1371/journal.pntd.0002243. Print 2013.

3.

Mutational analysis of the West Nile virus NS4B protein.

Wicker JA, Whiteman MC, Beasley DW, Davis CT, McGee CE, Lee JC, Higgs S, Kinney RM, Huang CY, Barrett AD.

Virology. 2012 Apr 25;426(1):22-33. doi: 10.1016/j.virol.2011.11.022. Epub 2012 Feb 6.

4.

Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.

Brewoo JN, Kinney RM, Powell TD, Arguello JJ, Silengo SJ, Partidos CD, Huang CY, Stinchcomb DT, Osorio JE.

Vaccine. 2012 Feb 14;30(8):1513-20. doi: 10.1016/j.vaccine.2011.11.072. Epub 2011 Dec 13.

5.

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness.

Whiteman MC, Wicker JA, Kinney RM, Huang CY, Solomon T, Barrett AD.

Vaccine. 2011 Dec 6;29(52):9702-10. doi: 10.1016/j.vaccine.2011.09.036. Epub 2011 Sep 21.

PMID:
21945257
6.

Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate.

Langevin SA, Bowen RA, Ramey WN, Sanders TA, Maharaj PD, Fang Y, Cornelius J, Barker CM, Reisen WK, Beasley DW, Barrett AD, Kinney RM, Huang CY, Brault AC.

J Gen Virol. 2011 Dec;92(Pt 12):2810-20. doi: 10.1099/vir.0.035535-0. Epub 2011 Aug 24.

7.

Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines.

Wiggan O, Livengood JA, Silengo SJ, Kinney RM, Osorio JE, Huang CY, Stinchcomb DT.

Vaccine. 2011 Oct 6;29(43):7456-62. doi: 10.1016/j.vaccine.2011.07.054. Epub 2011 Jul 29.

8.

Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.

Osorio JE, Huang CY, Kinney RM, Stinchcomb DT.

Vaccine. 2011 Sep 23;29(42):7251-60. doi: 10.1016/j.vaccine.2011.07.020. Epub 2011 Jul 21. Review.

9.

Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques.

Osorio JE, Brewoo JN, Silengo SJ, Arguello J, Moldovan IR, Tary-Lehmann M, Powell TD, Livengood JA, Kinney RM, Huang CY, Stinchcomb DT.

Am J Trop Med Hyg. 2011 Jun;84(6):978-87. doi: 10.4269/ajtmh.2011.10-0592.

10.

Replication of the primary dog kidney-53 dengue 2 virus vaccine candidate in Aedes aegypti is modulated by a mutation in the 5' untranslated region and amino acid substitutions in nonstructural proteins 1 and 3.

Brault AC, Kinney RM, Maharaj PD, Green EN, Reisen WK, Huang CY.

Vector Borne Zoonotic Dis. 2011 Jun;11(6):683-9. doi: 10.1089/vbz.2010.0150. Epub 2011 Feb 1.

PMID:
21284523
11.

Characterization of recombinant dengue-2 virus derived from a single nucleotide substitution in the 5' noncoding region.

Leardkamolkarn V, Sirigulpanit W, Kinney RM.

J Biomed Biotechnol. 2010;2010:934694. doi: 10.1155/2010/934694. Epub 2010 Mar 22.

12.

The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion.

Huang CY, Butrapet S, Moss KJ, Childers T, Erb SM, Calvert AE, Silengo SJ, Kinney RM, Blair CD, Roehrig JT.

Virology. 2010 Jan 20;396(2):305-15. doi: 10.1016/j.virol.2009.10.027. Epub 2009 Nov 12.

13.

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus.

Whiteman MC, Li L, Wicker JA, Kinney RM, Huang C, Beasley DW, Chung KM, Diamond MS, Solomon T, Barrett AD.

Vaccine. 2010 Jan 22;28(4):1075-83. doi: 10.1016/j.vaccine.2009.10.112. Epub 2009 Nov 5.

PMID:
19896447
14.

Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus.

Stein DA, Huang CY, Silengo S, Amantana A, Crumley S, Blouch RE, Iversen PL, Kinney RM.

J Antimicrob Chemother. 2008 Sep;62(3):555-65. doi: 10.1093/jac/dkn221. Epub 2008 Jun 19.

PMID:
18567576
15.

A single positively selected West Nile viral mutation confers increased virogenesis in American crows.

Brault AC, Huang CY, Langevin SA, Kinney RM, Bowen RA, Ramey WN, Panella NA, Holmes EC, Powers AM, Miller BR.

Nat Genet. 2007 Sep;39(9):1162-6. Epub 2007 Aug 12.

16.

Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes.

Bryant JE, Calvert AE, Mesesan K, Crabtree MB, Volpe KE, Silengo S, Kinney RM, Huang CY, Miller BR, Roehrig JT.

Virology. 2007 Sep 30;366(2):415-23. Epub 2007 Jun 1.

17.
18.

A combination of naturally occurring mutations in North American West Nile virus nonstructural protein genes and in the 3' untranslated region alters virus phenotype.

Davis CT, Galbraith SE, Zhang S, Whiteman MC, Li L, Kinney RM, Barrett AD.

J Virol. 2007 Jun;81(11):6111-6. Epub 2007 Mar 21.

19.

Avian virulence and thermostable replication of the North American strain of West Nile virus.

Kinney RM, Huang CY, Whiteman MC, Bowen RA, Langevin SA, Miller BR, Brault AC.

J Gen Virol. 2006 Dec;87(Pt 12):3611-22.

PMID:
17098976
20.

A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus.

Zhang S, Li L, Woodson SE, Huang CY, Kinney RM, Barrett AD, Beasley DW.

Virology. 2006 Sep 15;353(1):35-40. Epub 2006 Jun 27.

21.

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

Wicker JA, Whiteman MC, Beasley DW, Davis CT, Zhang S, Schneider BS, Higgs S, Kinney RM, Barrett AD.

Virology. 2006 Jun 5;349(2):245-53. Epub 2006 Apr 19.

22.

Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge.

Calvert AE, Huang CY, Kinney RM, Roehrig JT.

J Gen Virol. 2006 Feb;87(Pt 2):339-46.

PMID:
16432020
23.
24.

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.

Beasley DW, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett AD.

J Virol. 2005 Jul;79(13):8339-47.

25.

Control of translation by the 5'- and 3'-terminal regions of the dengue virus genome.

Chiu WW, Kinney RM, Dreher TW.

J Virol. 2005 Jul;79(13):8303-15.

26.

Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells.

Petrakova O, Volkova E, Gorchakov R, Paessler S, Kinney RM, Frolov I.

J Virol. 2005 Jun;79(12):7597-608.

28.

Recombination and flavivirus vaccines: a commentary.

Monath TP, Kanesa-Thasan N, Guirakhoo F, Pugachev K, Almond J, Lang J, Quentin-Millet MJ, Barrett AD, Brinton MA, Cetron MS, Barwick RS, Chambers TJ, Halstead SB, Roehrig JT, Kinney RM, Rico-Hesse R, Strauss JH.

Vaccine. 2005 Apr 27;23(23):2956-8. No abstract available.

PMID:
15811640
29.

Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.

Kinney RM, Huang CY, Rose BC, Kroeker AD, Dreher TW, Iversen PL, Stein DA.

J Virol. 2005 Apr;79(8):5116-28.

30.

Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses.

Crabtree MB, Kinney RM, Miller BR.

Arch Virol. 2005 Apr;150(4):771-86. Epub 2004 Dec 10.

PMID:
15592895
31.

[Circulation of West Nile virus (Flaviviridae, Flavivirus) and some other arboviruses in the ecosystems of Volga delta, Volga-Akhtuba flood-lands and adjoining arid regions (2000-2002)].

L'vov DK, Kovtunov AI, Iashkulov KB, Gromashevskiĭ VL, Dzharkenov AF, Shchelkanov MIu, Kulikova LN, Savage HM, Chimidova NM, Mikhaliaeva LB, Vasil'ev AV, Galkina IV, Prilipov AG, Kinney RM, Samokhvalov EI, Bushkieva BTs, Gubler DJ, Al'khovskiĭ SK, Aristova VA, Deriabin PG, Butenko AM, Moskvina TM, L'vov DN, Zlobina LV, Liapina OV, Sadykova GK, Shatalov AG, Usachev VE, Voronina AG, Luneva LI.

Vopr Virusol. 2004 May-Jun;49(3):45-51. Russian.

PMID:
15188655
32.

Molecular determinants of virulence of West Nile virus in North America.

Beasley DW, Davis CT, Whiteman M, Granwehr B, Kinney RM, Barrett AD.

Arch Virol Suppl. 2004;(18):35-41. Review.

PMID:
15119761
33.

Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Huang CY, Butrapet S, Tsuchiya KR, Bhamarapravati N, Gubler DJ, Kinney RM.

J Virol. 2003 Nov;77(21):11436-47.

34.

[Analysis of new variants of West Nile fever virus].

Prilipov AG, Kinney RM, Samokhvalov EI, Savage HM, Al'khovskiĭ SV, Tsuchiya KR, Gromashevskiĭ VL, Sadykova GK, Shatalov AG, Vyshemirskiĭ OI, Usachev EV, Mokhonov VV, Voronina AG, Butenko AM, Larichev VF, Zhukov AN, Kovtunov AI, Gubler DJ, L'vov DK.

Vopr Virusol. 2002 Jul-Aug;47(4):36-41. Russian.

PMID:
12271724
35.

Specific detection of chikungunya virus using a RT-PCR/nested PCR combination.

Pfeffer M, Linssen B, Parke MD, Kinney RM.

J Vet Med B Infect Dis Vet Public Health. 2002 Feb;49(1):49-54.

PMID:
11911593
36.

Development of new vaccines against dengue fever and Japanese encephalitis.

Kinney RM, Huang CY.

Intervirology. 2001;44(2-3):176-97. Review.

PMID:
11509879
38.

Development of reverse transcription-PCR assays specific for detection of equine encephalitis viruses.

Linssen B, Kinney RM, Aguilar P, Russell KL, Watts DM, Kaaden OR, Pfeffer M.

J Clin Microbiol. 2000 Apr;38(4):1527-35.

39.

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Huang CY, Butrapet S, Pierro DJ, Chang GJ, Hunt AR, Bhamarapravati N, Gubler DJ, Kinney RM.

J Virol. 2000 Apr;74(7):3020-8.

40.
41.

Sequencing of prototype viruses in the Venezuelan equine encephalitis antigenic complex.

Meissner JD, Huang CY, Pfeffer M, Kinney RM.

Virus Res. 1999 Oct;64(1):43-59.

PMID:
10500282
42.

Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks.

Weaver SC, Pfeffer M, Marriott K, Kang W, Kinney RM.

Am J Trop Med Hyg. 1999 Mar;60(3):441-8.

PMID:
10466974
43.

Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex.

Kinney RM, Pfeffer M, Tsuchiya KR, Chang GJ, Roehrig JT.

Am J Trop Med Hyg. 1998 Dec;59(6):952-64.

PMID:
9886206
45.
46.

Genus-specific detection of alphaviruses by a semi-nested reverse transcription-polymerase chain reaction.

Pfeffer M, Proebster B, Kinney RM, Kaaden OR.

Am J Trop Med Hyg. 1997 Dec;57(6):709-18.

PMID:
9430533
47.

Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.

Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ.

Virology. 1997 Apr 14;230(2):300-8.

48.

Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus.

Chang GJ, Cropp BC, Kinney RM, Trent DW, Gubler DJ.

J Virol. 1995 Sep;69(9):5773-80.

49.

Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus.

Mathews JH, Kinney RM, Roehrig JT, Barrett AD, Trent DW.

Vaccine. 1994 May;12(7):620-4.

PMID:
8085379
50.

Supplemental Content

Loading ...
Support Center